|
Natural killer cell signalling
|
3.06 × 10-4
|
23/112 (0.205)
|
|
Communication between innate and adaptive immune cells
|
4.11 × 10-4
|
17/89 (0.191)
|
|
TREM1 signalling
|
2.20 × 10-3
|
15/69 (0.217)
|
|
Dendritic cell maturation
|
4.96 × 10-3
|
29/174 (0.167)
|
|
Cysteine metabolism
|
7.43 × 10-3
|
9/90 (0.100)
|
|
JAK/STAT signalling
|
8.22 × 10-3
|
15/64 (0.234)
|
|
NRF2-mediated oxidative stress response
|
8.98 × 10-3
|
35/183 (0.191)
|
|
T cell receptor signalling
|
1.08 × 10-2
|
20/107 (0.187)
|
|
IL6 signalling
|
1.52 × 10-2
|
20/93 (0.215)
|
|
CCR5 signalling in macrophages
|
1.84 × 10-2
|
16/92 (0.174)
|
|
Chemokine signalling
|
1.92 × 10-2
|
15/75 (0.200)
|
|
Calcium-induced T-lymphocyte apoptosis
|
2.07 × 10-2
|
12/66 (0.182)
|
|
IL-17 signalling
|
2.21 × 10-2
|
16/74 (0.216)
|
|
Prolactin signalling
|
2.21 × 10-2
|
16/75 (0.213)
|
|
Synaptic long term potentiation
|
2.22 × 10-2
|
19/113 (0.168)
|
|
Toll-like receptor signalling
|
2.63 × 10-2
|
11/54 (0.204)
|
|
FLT3 signalling in hematopoietic progenitor cells
|
2.77 × 10-2
|
15/74 (0.203)
|
|
Systemic lupus erythematosus signalling
|
2.81 × 10-2
|
20/151 (0.132)
|
|
Renin angiotensin signalling
|
3.01 × 10-2
|
21/120 (0.175)
|
|
Phospholipase C signalling
|
3.28 × 10-2
|
39/253 (0.154)
|
|
Oncostatin M signalling
|
3.36 × 10-2
|
9/35 (0.257)
|
|
Thyroid cancer signalling
|
3.36 × 10-2
|
9/42 (0.214)
|
|
B cell receptor signalling
|
3.72 × 10-2
|
25/154 (0.162)
|
|
Interferon signalling
|
3.97 × 10-2
|
6/30 (0.200)
|
|
Production of nitric oxide and reactive oxygen species in macrophages
|
4.13 × 10-2
|
28/185 (0.151)
|
|
NF-κB signalling
|
4.17 × 10-2
|
25/152 (0.164)
|
|
Notch signalling
|
4.29 × 10-2
|
8/43 (0.186)
|
|
IL10 signalling
|
4.36 × 10-2
|
13/70 (0.186)
|
|
P38 MAPK signalling
|
4.57 × 10-2
|
17/97 (0.175)
|
|
Role of NFAT in regulation of the immune response
|
4.70 × 10-2
|
29/196 (0.148)
|
|
Parkinson's signalling
|
5.00 × 10-2
|
5/17 (0.294)
|
